세포 배양 배지 및 시약 시장(2026-2030년)

The global cell culture media and reagents market is forecasted to grow by USD 6331.2 mn during 2025-2030, accelerating at a CAGR of 8.4% during the forecast period. The report on the global cell culture media and reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global biopharmaceutical production escalates continuous demand for specialized media, expanding clinical pipeline for gene therapies drives need for reagents, transition toward chemically defined media enhances batch consistency and reproducibility.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global cell culture media and reagents market is segmented as below:

By End-User

• Pharmaceutical and biotechnology industry
• Academic institutions and research laboratories
• Others

By Product

• Media
• Reagents

By Application

• Biopharmaceutical production
• Diagnostics
• Drug discovery
• Tissue engineering and regenerative medicine
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Asia
• Europe
  • Germany
  • UK
  • France
  • Italy
  • The Netherlands
  • Spain
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the establishment of regional media development facilities accelerates custom biomanufacturing services as one of the prime reasons driving the global cell culture media and reagents market growth during the next few years. Also, implementation of continuous perfusion bioprocessing requires high density media formulations and integration of single use packaging enhances media stability and cleanroom efficiency will lead to sizable demand in the market.

The report on the global cell culture media and reagents market covers the following areas:

• Global cell culture media and reagents market sizing
• Global cell culture media and reagents market forecast
• Global cell culture media and reagents market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global cell culture media and reagents market vendors that include Beijing Yocon Biology Technology, Bio Techne Corp., BIOWEST SAS, Capricorn Scientific GmbH, Corning Inc., FUJIFILM Holdings Corp., HiMedia Laboratories Pvt. Ltd., InVitria Inc., Jianshun Biosciences Co. Ltd., Kohjin Bio Co. Ltd., Lonza Group Ltd., Merck KGaA, Miltenyi Biotec BV and Co. KG, MP Biomedicals Inc., PromoCell GmbH, Sartorius AG, Shanghai OPM Biosciences Co., Sino Biological Inc., Takara Bio Inc., Thermo Fisher Scientific Inc.. Also, the global cell culture media and reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Cell Culture Media And Reagents Market 2020 - 2024
  • Historic Market Size - Data Table on Global Cell Culture Media And Reagents Market 2020 - 2024 ($ million)
• 5.2 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.3 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.4 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global cell culture media and reagents market
• 6.2 Impact of geopolitical conflicts on global cell culture media and reagents market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by End-user

• 8.1 Market segments
• 8.2 Comparison by End-user
• 8.3 Pharmaceutical and biotechnology industry - Market size and forecast 2025-2030
• 8.4 Academic institutions and research laboratories - Market size and forecast 2025-2030
• 8.5 Others - Market size and forecast 2025-2030
• 8.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

9 Market Segmentation by Product

• 9.1 Market segments
• 9.2 Comparison by Product
• 9.3 Media - Market size and forecast 2025-2030
• 9.4 Reagents - Market size and forecast 2025-2030
• 9.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

10 Market Segmentation by Application

• 10.1 Market segments
• 10.2 Comparison by Application
• 10.3 Biopharmaceutical production - Market size and forecast 2025-2030
• 10.4 Diagnostics - Market size and forecast 2025-2030
• 10.5 Drug discovery - Market size and forecast 2025-2030
• 10.6 Tissue engineering and regenerative medicine - Market size and forecast 2025-2030
• 10.7 Others - Market size and forecast 2025-2030
• 10.8 Market opportunity by Application
  • Market opportunity by Application ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Asia - Market size and forecast 2025-2030
  • 12.4.1 China - Market size and forecast 2025-2030
  • 12.4.2 Japan - Market size and forecast 2025-2030
  • 12.4.3 India - Market size and forecast 2025-2030
  • 12.4.4 Singapore - Market size and forecast 2025-2030
  • 12.4.5 Taiwan - Market size and forecast 2025-2030
  • 12.4.6 Thailand - Market size and forecast 2025-2030
• 12.5 Europe - Market size and forecast 2025-2030
  • 12.5.1 Germany - Market size and forecast 2025-2030
  • 12.5.2 UK - Market size and forecast 2025-2030
  • 12.5.3 France - Market size and forecast 2025-2030
  • 12.5.4 Italy - Market size and forecast 2025-2030
  • 12.5.5 The Netherlands - Market size and forecast 2025-2030
  • 12.5.6 Spain - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 South Africa - Market size and forecast 2025-2030
  • 12.6.5 Turkey - Market size and forecast 2025-2030
  • 12.6.6 Argentina - Market size and forecast 2025-2030
  • 12.6.7 Egypt - Market size and forecast 2025-2030
  • 12.6.8 Chile - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising global biopharmaceutical production escalates continuous demand for specialized media
  • Expanding clinical pipeline for gene therapies drives need for reagents
  • Transition toward chemically defined media enhances batch consistency and reproducibility
• 13.2 Market challenges
  • Raw material sourcing volatility creates severe production disruptions across global markets
  • High development expenditures limit adoption of advanced custom cell formulations
  • Bioprocess scaling difficulties complicate transition from research to commercial production
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Establishment of regional media development facilities accelerates custom biomanufacturing services
  • Implementation of continuous perfusion bioprocessing requires high density media formulations
  • Integration of single use packaging enhances media stability and cleanroom efficiency

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Beijing Yocon Biology Technology
  • Beijing Yocon Biology Technology - Overview
  • Beijing Yocon Biology Technology - Product / Service
  • Beijing Yocon Biology Technology - Key offerings
  • SWOT
• 15.5 Bio Techne Corp.
  • Bio Techne Corp. - Overview
  • Bio Techne Corp. - Business segments
  • Bio Techne Corp. - Key news
  • Bio Techne Corp. - Key offerings
  • Bio Techne Corp. - Segment focus
  • SWOT
• 15.6 Corning Inc.
  • Corning Inc. - Overview
  • Corning Inc. - Business segments
  • Corning Inc. - Key offerings
  • Corning Inc. - Segment focus
  • SWOT
• 15.7 FUJIFILM Holdings Corp.
  • FUJIFILM Holdings Corp. - Overview
  • FUJIFILM Holdings Corp. - Business segments
  • FUJIFILM Holdings Corp. - Key news
  • FUJIFILM Holdings Corp. - Key offerings
  • FUJIFILM Holdings Corp. - Segment focus
  • SWOT
• 15.8 HiMedia Laboratories Pvt. Ltd.
  • HiMedia Laboratories Pvt. Ltd. - Overview
  • HiMedia Laboratories Pvt. Ltd. - Product / Service
  • HiMedia Laboratories Pvt. Ltd. - Key offerings
  • SWOT
• 15.9 Kohjin Bio Co. Ltd.
  • Kohjin Bio Co. Ltd. - Overview
  • Kohjin Bio Co. Ltd. - Business segments
  • Kohjin Bio Co. Ltd. - Key offerings
  • Kohjin Bio Co. Ltd. - Segment focus
  • SWOT
• 15.10 Lonza Group Ltd.
  • Lonza Group Ltd. - Overview
  • Lonza Group Ltd. - Business segments
  • Lonza Group Ltd. - Key news
  • Lonza Group Ltd. - Key offerings
  • Lonza Group Ltd. - Segment focus
  • SWOT
• 15.11 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
• 15.12 Miltenyi Biotec BV and Co. KG
  • Miltenyi Biotec BV and Co. KG - Overview
  • Miltenyi Biotec BV and Co. KG - Product / Service
  • Miltenyi Biotec BV and Co. KG - Key offerings
  • SWOT
• 15.13 MP Biomedicals Inc.
  • MP Biomedicals Inc. - Overview
  • MP Biomedicals Inc. - Product / Service
  • MP Biomedicals Inc. - Key offerings
  • SWOT
• 15.14 PromoCell GmbH
  • PromoCell GmbH - Overview
  • PromoCell GmbH - Product / Service
  • PromoCell GmbH - Key offerings
  • SWOT
• 15.15 Sartorius AG
  • Sartorius AG - Overview
  • Sartorius AG - Business segments
  • Sartorius AG - Key offerings
  • Sartorius AG - Segment focus
  • SWOT
• 15.16 Shanghai OPM Biosciences Co.
  • Shanghai OPM Biosciences Co. - Overview
  • Shanghai OPM Biosciences Co. - Product / Service
  • Shanghai OPM Biosciences Co. - Key offerings
  • SWOT
• 15.17 Takara Bio Inc.
  • Takara Bio Inc. - Overview
  • Takara Bio Inc. - Product / Service
  • Takara Bio Inc. - Key offerings
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations